Ratchet effect

Last updated

A mechanical ratchet moving in its "forward" direction and unable to move backward. Ratchet example.gif
A mechanical ratchet moving in its "forward" direction and unable to move backward.

The ratchet effect is a concept in sociology and economics illustrating the difficulty with reversing a course of action once a specific thing has occurred, analogous with the mechanical ratchet that allows movement in one direction and seizes or tightens in the opposite. The concept has been applied to multiple fields of study and is related to the phenomena of scope creep, mission creep, and feature creep.

Contents

Background

The ratchet effect first came to light in Alan Peacock and Jack Wiseman's 1961 report "The Growth of Public Expenditure in the United Kingdom." Peacock and Wiseman found that public spending increases like a ratchet following periods of crisis. [1]

The term was later expanded upon by American historian Robert Higgs in the 1987 book Crisis and Leviathan, highlighting Peacock and Wiseman's research as it relates to governments experiencing difficulty in rolling back huge bureaucratic organizations created initially for temporary needs, such as wartime measures, natural disasters, or economic crises. [2]

The effect may likewise afflict large businesses with myriad layers of bureaucracy which resist reform or dismantling. [3] In workplaces, "ratchet effects refer to the tendency for central controllers to base next year's targets on last year's performance, meaning that managers who expect still to be in place in the next target period have a perverse incentive not to exceed targets even if they could easily do so." [4]

Applications

Famine cycle

Garrett Hardin, a biologist and environmentalist, used the phrase to describe how food aid keeps people alive who would otherwise die in a famine. They live and multiply in better times, making another bigger crisis inevitable, since the supply of food has not been increased. [5]

Production strategy

Jean Tirole used the concept in his pioneering work on regulation and monopolies. The ratchet effect can denote an economic strategy arising in an environment where incentive depends on both current and past production, such as in a competitive industry employing piece rates. The producers observe that since incentive is readjusted based on their production, any increase in production confers only a temporary increase in incentive while requiring a permanently greater expenditure of work. They therefore decide not to reveal hidden production capacity unless forced to do so.

Game theory

The ratchet effect is central to the mathematical Parrondo's paradox.

Cultural anthropology

In 1999 comparative psychologist Michael Tomasello used the ratchet effect metaphor to shed light on the evolution of culture. [6] He explains that the sharedness of human culture means that it is cumulative in character. Once a certain invention has been made, it can jump from one mind to another (by means of imitation) and thus a whole population can acquire a new trait (and so the ratchet has gone "up" one tooth). Comparative psychologist Claudio Tennie, Tomasello, and Josep Call call this the "cultural ratchet" and they describe it, amongst primates, as being unique to human culture. [7]

Developmental biology

Receptors which initiate cell fate transduction cascades, in early embryo development, exhibit a ratchet effect in response to morphogen concentrations. [8] The low receptor occupancy permits increases in receptor occupancy which alter the cell fate, but the high receptor affinity does not allow ligand dissociation leading to a cell fate of a lower concentration.

Technology regulation

The ratchet effect is reflected in the Collingridge dilemma.

Consumer products

The ratchet effect can be seen in long-term trends in the production of many consumer goods. Year by year, automobiles gradually acquire more features. Competitive pressures make it hard for manufacturers to cut back on the features unless forced by a true scarcity of raw materials (e.g., an oil shortage that drives costs up radically). University textbook publishers gradually get "stuck" in producing books that have excess content and features.

In software development, products which compete often will use specification lists of competitive products to add features, presuming that they must provide all of the features of the competitive product, plus add additional functionality. This can lead to "feature creep" in which it is considered necessary to add all of a competitor's features whether or not customers will use them.

Airlines initiate frequent-flyer programs that become ever harder to terminate. Successive generations of home appliances gradually acquire more features; new editions of software acquire more features; and so on. With all of these goods, there is ongoing debate as to whether the added features truly improve usability, or simply increase the tendency for people to buy the goods.

Trade legislation

The term was included by the MAI Negotiating Group in the 1990s as the essence of a device to enforce legislative progress toward "free trade" by preventing legislative rollback with the compulsory assent of governments as a condition of participation.

Rollback is the liberalisation process by which the reduction and eventual elimination of nonconforming measures to the MAI would take place. It is a dynamic element linked with standstill, which provides its starting point. Combined with standstill, it would produce a "ratchet effect", where any new liberalisation measures would be "locked in" so they could not be rescinded or nullified over time. [9]

See also

Related Research Articles

<span class="mw-page-title-main">Neurotransmitter</span> Chemical substance that enables neurotransmission

A neurotransmitter is a signaling molecule secreted by a neuron to affect another cell across a synapse. The cell receiving the signal, or target cell, may be another neuron, but could also be a gland or muscle cell.

<span class="mw-page-title-main">Phagocytosis</span> Cell membrane engulfing a large particle

Phagocytosis is the process by which a cell uses its plasma membrane to engulf a large particle, giving rise to an internal compartment called the phagosome. It is one type of endocytosis. A cell that performs phagocytosis is called a phagocyte.

<span class="mw-page-title-main">Natural killer cell</span> Type of cytotoxic lymphocyte

Natural killer cells, also known as NK cells, are a type of cytotoxic lymphocyte critical to the innate immune system. They are a kind of large granular lymphocytes (LGL), and belong to the rapidly expanding family of known innate lymphoid cells (ILC) and represent 5–20% of all circulating lymphocytes in humans. The role of NK cells is analogous to that of cytotoxic T cells in the vertebrate adaptive immune response. NK cells provide rapid responses to virus-infected cells, stressed cells, tumor cells, and other intracellular pathogens based on signals from several activating and inhibitory receptors. Most immune cells detect the antigen presented on major histocompatibility complex I (MHC-I) on infected cell surfaces, but NK cells can recognize and kill stressed cells in the absence of antibodies and MHC, allowing for a much faster immune reaction. They were named "natural killers" because of the notion that they do not require activation to kill cells that are missing "self" markers of MHC class I. This role is especially important because harmful cells that are missing MHC I markers cannot be detected and destroyed by other immune cells, such as T lymphocyte cells.

<span class="mw-page-title-main">Erythropoietin</span> Protein that stimulates red blood cell production

Erythropoietin, also known as erythropoetin, haematopoietin, or haemopoietin, is a glycoprotein cytokine secreted mainly by the kidneys in response to cellular hypoxia; it stimulates red blood cell production (erythropoiesis) in the bone marrow. Low levels of EPO are constantly secreted in sufficient quantities to compensate for normal red blood cell turnover. Common causes of cellular hypoxia resulting in elevated levels of EPO include any anemia, and hypoxemia due to chronic lung disease and mouth disease.

<span class="mw-page-title-main">Glucocorticoid</span> Class of corticosteroids

Glucocorticoids are a class of corticosteroids, which are a class of steroid hormones. Glucocorticoids are corticosteroids that bind to the glucocorticoid receptor that is present in almost every vertebrate animal cell. The name "glucocorticoid" is a portmanteau and is composed from its role in regulation of glucose metabolism, synthesis in the adrenal cortex, and its steroidal structure.

<span class="mw-page-title-main">Receptor (biochemistry)</span> Protein molecule receiving signals for a cell

In biochemistry and pharmacology, receptors are chemical structures, composed of protein, that receive and transduce signals that may be integrated into biological systems. These signals are typically chemical messengers which bind to a receptor and produce physiological responses such as change in the electrical activity of a cell. For example, GABA, an inhibitory neurotransmitter, inhibits electrical activity of neurons by binding to GABAA receptors. There are three main ways the action of the receptor can be classified: relay of signal, amplification, or integration. Relaying sends the signal onward, amplification increases the effect of a single ligand, and integration allows the signal to be incorporated into another biochemical pathway.

<span class="mw-page-title-main">Receptor antagonist</span> Type of receptor ligand or drug that blocks a biological response

A receptor antagonist is a type of receptor ligand or drug that blocks or dampens a biological response by binding to and blocking a receptor rather than activating it like an agonist. Antagonist drugs interfere in the natural operation of receptor proteins. They are sometimes called blockers; examples include alpha blockers, beta blockers, and calcium channel blockers. In pharmacology, antagonists have affinity but no efficacy for their cognate receptors, and binding will disrupt the interaction and inhibit the function of an agonist or inverse agonist at receptors. Antagonists mediate their effects by binding to the active site or to the allosteric site on a receptor, or they may interact at unique binding sites not normally involved in the biological regulation of the receptor's activity. Antagonist activity may be reversible or irreversible depending on the longevity of the antagonist–receptor complex, which, in turn, depends on the nature of antagonist–receptor binding. The majority of drug antagonists achieve their potency by competing with endogenous ligands or substrates at structurally defined binding sites on receptors.

<span class="mw-page-title-main">Pharmacodynamics</span> Branch of pharmacology

Pharmacodynamics (PD) is the study of the biochemical and physiologic effects of drugs. The effects can include those manifested within animals, microorganisms, or combinations of organisms.

<span class="mw-page-title-main">Leukotriene</span> Class of inflammation mediator molecules

Leukotrienes are a family of eicosanoid inflammatory mediators produced in leukocytes by the oxidation of arachidonic acid (AA) and the essential fatty acid eicosapentaenoic acid (EPA) by the enzyme arachidonate 5-lipoxygenase.

<span class="mw-page-title-main">Interleukin 4</span> Mammalian protein found in Mus musculus

The interleukin 4 is a cytokine that induces differentiation of naive helper T cells (Th0 cells) to Th2 cells. Upon activation by IL-4, Th2 cells subsequently produce additional IL-4 in a positive feedback loop. IL-4 is produced primarily by mast cells, Th2 cells, eosinophils and basophils. It is closely related and has functions similar to IL-13.

<span class="mw-page-title-main">Aminophylline</span> Chemical compound

Aminophylline is a compound of the bronchodilator theophylline with ethylenediamine in 2:1 ratio. The ethylenediamine improves solubility, and the aminophylline is usually found as a dihydrate.

A co-receptor is a cell surface receptor that binds a signalling molecule in addition to a primary receptor in order to facilitate ligand recognition and initiate biological processes, such as entry of a pathogen into a host cell.

<span class="mw-page-title-main">Interleukin 13</span> Protein and coding gene in humans

Interleukin 13 (IL-13) is a protein that in humans is encoded by the IL13 gene. IL-13 was first cloned in 1993 and is located on chromosome 5q31.1 with a length of 1.4kb. It has a mass of 13 kDa and folds into 4 alpha helical bundles. The secondary structural features of IL-13 are similar to that of Interleukin 4 (IL-4); however it only has 25% sequence identity to IL-4 and is capable of IL-4 independent signaling. IL-13 is a cytokine secreted by T helper type 2 (Th2) cells, CD4 cells, natural killer T cell, mast cells, basophils, eosinophils and nuocytes. Interleukin-13 is a central regulator in IgE synthesis, goblet cell hyperplasia, mucus hypersecretion, airway hyperresponsiveness, fibrosis and chitinase up-regulation. It is a mediator of allergic inflammation and different diseases including asthma, and atopic dermatitis.

Compartments can be simply defined as separate, different, adjacent cell populations, which upon juxtaposition, create a lineage boundary. This boundary prevents cell movement from cells from different lineages across this barrier, restricting them to their compartment. Subdivisions are established by morphogen gradients and maintained by local cell-cell interactions, providing functional units with domains of different regulatory genes, which give rise to distinct fates. Compartment boundaries are found across species. In the hindbrain of vertebrate embryos, rhombomeres are compartments of common lineage outlined by expression of Hox genes. In invertebrates, the wing imaginal disc of Drosophila provides an excellent model for the study of compartments. Although other tissues, such as the abdomen, and even other imaginal discs are compartmentalized, much of our understanding of key concepts and molecular mechanisms involved in compartment boundaries has been derived from experimentation in the wing disc of the fruit fly.

<span class="mw-page-title-main">Tetramethylenedisulfotetramine</span> Chemical compound

Tetramethylenedisulfotetramine (TETS) is an organic compound used as a rodenticide. It is an odorless, tasteless white powder that is slightly soluble in water, DMSO and acetone, and insoluble in methanol and ethanol. It is a sulfamide derivative. It can be synthesized by reacting sulfamide with formaldehyde solution in acidified water. When crystallized from acetone, it forms cubic crystals with a melting point of 255–260 °C.

Ca<sup>2+</sup>/calmodulin-dependent protein kinase II Class of enzymes

Ca2+
/calmodulin-dependent protein kinase II
is a serine/threonine-specific protein kinase that is regulated by the Ca2+
/calmodulin complex. CaMKII is involved in many signaling cascades and is thought to be an important mediator of learning and memory. CaMKII is also necessary for Ca2+
homeostasis and reuptake in cardiomyocytes, chloride transport in epithelia, positive T-cell selection, and CD8 T-cell activation.

<span class="mw-page-title-main">CD27</span> Protein in the tumor necrosis factor receptor superfamily

CD27 is a member of the tumor necrosis factor receptor superfamily. It is currently of interest to immunologists as a co-stimulatory immune checkpoint molecule, and is the target of an anti-cancer drug in clinical trials.

Cutamesine (SA 4503) is a synthetic sigma receptor agonist which is selective for the σ1 receptor, a chaperone protein mainly found in the endoplasmic reticulum of cells in the central nervous system. These σ1 receptors play a key role in the modulation of Ca2+ release and apoptosis. Cutamesine's activation of the σ1 receptor is tied to a variety of physiological phenomena in the CNS, including activation of dopamine-releasing neurons and repression of the MAPK/ERK pathway.

<span class="mw-page-title-main">Macitentan</span> Chemical compound

Macitentan, sold under the brand name Opsumit, is an endothelin receptor antagonist developed by Actelion and approved for the treatment of pulmonary arterial hypertension (PAH). Macitentan is a dual endothelin receptor antagonist, meaning that it acts as an antagonist of two endothelin (ET) receptor subtypes, ETA and ETB. However, macitentan has a 50-fold increased selectivity for the ETA subtype compared to the ETB subtype.

Drug antagonism refers to a medicine stopping the action or effect of another substance, preventing a biological response. The stopping actions are carried out by four major mechanisms, namely chemical, pharmacokinetic, receptor and physiological antagonism. The four mechanisms are widely used in reducing overstimulated physiological actions. Drug antagonists can be used in a variety of medications, including anticholinergics, antihistamines, etc. The antagonistic effect can be quantified by pharmacodynamics. Some can even serve as antidotes for toxicities and overdose.

References

  1. Alan Peacock and Jack Wiseman , 1961, ISBN   0-87014-071-X
  2. O'Reilly, Colin; Powell, Benjamin (2015). "War and the growth of government". European Journal of Political Economy. 40: 31–41. doi:10.1016/j.ejpoleco.2015.10.001.
  3. Robert Higgs Crisis and Leviathan, OUP, 1987, ISBN   0-19-505900-X
  4. Bevan, Gwyn; Hood, Christopher (15 August 2006). "What's Measured Is What Matters: Targets and Gaming in the English Public Health Care System". Public Administration. 84 (3): 517–538. doi:10.1111/j.1467-9299.2006.00600.x . Retrieved 18 May 2021.
  5. Hardin, Garrett (September 1974). "Lifeboat ethics: the case against helping the poor". Psychology Today. Vol. 8. pp. 38–43. reprint
  6. Tomasello, M. 1999. The Cultural Origins of Human Cognition. Cambridge, MA: Harvard University Press.
  7. Tennie, C.; Call, J.; Tomasello, M. (2009). "Ratcheting up the ratchet: on the evolution of cumulative culture". Phil. Trans. R. Soc. B. 364 (1528): 2405–2415. doi:10.1098/rstb.2009.0052. PMC   2865079 . PMID   19620111.
  8. Dyson, Steven; Gurdon, J.B (1998). "The Interpretation of Position in a Morphogen Gradient as Revealed by Occupancy of Activin Receptors". Cell. 93 (4): 557–568. doi: 10.1016/S0092-8674(00)81185-X . PMID   9604931. S2CID   2326620.
  9. "Mechanisms for standstill, rollback and listing of country specific reservations", Page 3 of note by MAI Negotiating Group chairman, OECD, 15 February 1996